Carmen Venegas, C. Marriott, T. Ho, K. Son, R. Jamil, Meher Jamal, M. Kjarsgaard, Chynna Huang, K. Radford, M. Dolovich, C. Farrow, T. Farncombe, Matthew Lubanovic, E. Haider, P. Nair, M. Mukherjee, S. Svenningsen
{"title":"非危重性COVID-19恢复后通气和灌注异常","authors":"Carmen Venegas, C. Marriott, T. Ho, K. Son, R. Jamil, Meher Jamal, M. Kjarsgaard, Chynna Huang, K. Radford, M. Dolovich, C. Farrow, T. Farncombe, Matthew Lubanovic, E. Haider, P. Nair, M. Mukherjee, S. Svenningsen","doi":"10.1080/24745332.2022.2054047","DOIUrl":null,"url":null,"abstract":"Abstract RATIONALE: Dyspnea and respiratory impairment are sequelae of COVID-19. OBJECTIVES The objectives of this study were to observe the prevalence and clinical relevance of ventilation (V) and perfusion (Q) impairment, evaluated by ventilation/perfusion-single-photon emission computed tomography-computed tomography (VQ-SPECT-CT), in individuals with no history of lung disease 4-weeks after recovery from noncritical COVID-19. METHODS We enrolled 25 COVID-19 patients’ post-recovery and 11 control subjects. All participants underwent VQ-SPECT-CT using 99mTc-Technegas for V and 99mTc-macroaggregated albumin for Q, spirometry, six-minute-walk-test, blood draw and completed the modified Medical Research Council (mMRC) dyspnea-scale and St. Georges Respiratory Questionnaire (SGRQ). VQ-SPECT-CT was reviewed to report lung function and structure abnormalities and ventilation-heterogeneity was quantified to evaluate associations with symptoms, exercise-capacity and inflammatory markers. MEASUREMENTS AND MAIN RESULTS: Of 25 post-COVID-19 participants, 9 were hospitalized and 16 home-isolated during acute-infection. A total of 88% of hospitalized and 44% of home-isolated participants were reported to have V defects (matched VQ defects: 63% and 44%; mismatched V defects: 38% and 13%), compared to 30% of never-COVID-19 controls (matched VQ defects: 30%, mismatched V defects: 10%) (P = 0.02 and P = 0.68, respectively). Ventilation-heterogeneity was greater in hospitalized (P = 0.003), but not home-isolated participants, compared to the never-COVID-19 controls. Post-COVID-19 ventilation-heterogeneity correlated with the dyspnea-scale (r = 0.45, P = 0.03), SGRQ-score (r = 0.41, P = 0.04), 6MWD (r=-0.49, P = 0.02), SpO2 (P = -0.55, P = 0.005), CT parenchymal opacities (r = 0.42, P = 0.04) and neutrophil percent (r = 0.45, P = 0.04), but not pro-inflammatory cytokines, C-reactive protein or D-dimer. CONCLUSIONS This small functional lung imaging study revealed ventilation impairment in individuals with no history of lung disease recovering from noncritical COVID-19 that was associated with parenchymal opacities, respiratory symptoms and exercise-capacity.","PeriodicalId":9471,"journal":{"name":"Canadian Journal of Respiratory, Critical Care, and Sleep Medicine","volume":"22 1","pages":"304 - 313"},"PeriodicalIF":1.5000,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Ventilation and perfusion abnormalities following recovery from noncritical COVID-19\",\"authors\":\"Carmen Venegas, C. Marriott, T. Ho, K. Son, R. Jamil, Meher Jamal, M. Kjarsgaard, Chynna Huang, K. Radford, M. Dolovich, C. Farrow, T. Farncombe, Matthew Lubanovic, E. Haider, P. Nair, M. Mukherjee, S. Svenningsen\",\"doi\":\"10.1080/24745332.2022.2054047\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Abstract RATIONALE: Dyspnea and respiratory impairment are sequelae of COVID-19. OBJECTIVES The objectives of this study were to observe the prevalence and clinical relevance of ventilation (V) and perfusion (Q) impairment, evaluated by ventilation/perfusion-single-photon emission computed tomography-computed tomography (VQ-SPECT-CT), in individuals with no history of lung disease 4-weeks after recovery from noncritical COVID-19. METHODS We enrolled 25 COVID-19 patients’ post-recovery and 11 control subjects. All participants underwent VQ-SPECT-CT using 99mTc-Technegas for V and 99mTc-macroaggregated albumin for Q, spirometry, six-minute-walk-test, blood draw and completed the modified Medical Research Council (mMRC) dyspnea-scale and St. Georges Respiratory Questionnaire (SGRQ). VQ-SPECT-CT was reviewed to report lung function and structure abnormalities and ventilation-heterogeneity was quantified to evaluate associations with symptoms, exercise-capacity and inflammatory markers. MEASUREMENTS AND MAIN RESULTS: Of 25 post-COVID-19 participants, 9 were hospitalized and 16 home-isolated during acute-infection. A total of 88% of hospitalized and 44% of home-isolated participants were reported to have V defects (matched VQ defects: 63% and 44%; mismatched V defects: 38% and 13%), compared to 30% of never-COVID-19 controls (matched VQ defects: 30%, mismatched V defects: 10%) (P = 0.02 and P = 0.68, respectively). Ventilation-heterogeneity was greater in hospitalized (P = 0.003), but not home-isolated participants, compared to the never-COVID-19 controls. Post-COVID-19 ventilation-heterogeneity correlated with the dyspnea-scale (r = 0.45, P = 0.03), SGRQ-score (r = 0.41, P = 0.04), 6MWD (r=-0.49, P = 0.02), SpO2 (P = -0.55, P = 0.005), CT parenchymal opacities (r = 0.42, P = 0.04) and neutrophil percent (r = 0.45, P = 0.04), but not pro-inflammatory cytokines, C-reactive protein or D-dimer. CONCLUSIONS This small functional lung imaging study revealed ventilation impairment in individuals with no history of lung disease recovering from noncritical COVID-19 that was associated with parenchymal opacities, respiratory symptoms and exercise-capacity.\",\"PeriodicalId\":9471,\"journal\":{\"name\":\"Canadian Journal of Respiratory, Critical Care, and Sleep Medicine\",\"volume\":\"22 1\",\"pages\":\"304 - 313\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2022-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Canadian Journal of Respiratory, Critical Care, and Sleep Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/24745332.2022.2054047\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian Journal of Respiratory, Critical Care, and Sleep Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/24745332.2022.2054047","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 1
摘要
理由:呼吸困难和呼吸障碍是COVID-19的后遗症。目的本研究的目的是观察通气/灌注-单光子发射计算机断层扫描-计算机断层扫描(VQ-SPECT-CT)评估通气(V)和灌注(Q)损伤的患病率和临床相关性,在非危重性COVID-19恢复后4周无肺部疾病史的个体中。方法选取25例COVID-19康复后患者和11例对照组。所有参与者均使用99mTc-Technegas进行VQ-SPECT-CT检测V和99mtc -巨聚集白蛋白检测Q、肺活量测定、6分钟步行试验、抽血,并完成改良的医学研究委员会(mMRC)呼吸困难量表和St. Georges呼吸问卷(SGRQ)。回顾VQ-SPECT-CT以报告肺功能和结构异常,并量化通气异质性以评估与症状、运动能力和炎症标志物的关联。测量方法和主要结果:在25名covid -19后参与者中,9人在急性感染期间住院,16人在家隔离。共有88%的住院和44%的家庭隔离参与者报告有V缺陷(匹配的VQ缺陷:63%和44%;V型缺陷不匹配:38%和13%),而从未感染covid -19的对照组为30% (VQ型缺陷匹配:30%,V型缺陷不匹配:10%)(P分别= 0.02和P = 0.68)。与从未感染covid -19的对照组相比,住院患者的通气异质性更大(P = 0.003),但在家隔离的参与者没有。新冠肺炎后通气异质性与呼吸困难量表(r= 0.45, P = 0.03)、sgrq评分(r= 0.41, P = 0.04)、6MWD (r=-0.49, P = 0.02)、SpO2 (P = -0.55, P = 0.005)、CT实质混浊(r= 0.42, P = 0.04)和中性粒细胞百分比(r= 0.45, P = 0.04)相关,但与促炎因子、c反应蛋白或d -二聚体无关。结论:这项小型肺功能影像学研究显示,在非危重性COVID-19康复后无肺部疾病史的个体中,通气障碍与实质混浊、呼吸症状和运动能力相关。
Ventilation and perfusion abnormalities following recovery from noncritical COVID-19
Abstract RATIONALE: Dyspnea and respiratory impairment are sequelae of COVID-19. OBJECTIVES The objectives of this study were to observe the prevalence and clinical relevance of ventilation (V) and perfusion (Q) impairment, evaluated by ventilation/perfusion-single-photon emission computed tomography-computed tomography (VQ-SPECT-CT), in individuals with no history of lung disease 4-weeks after recovery from noncritical COVID-19. METHODS We enrolled 25 COVID-19 patients’ post-recovery and 11 control subjects. All participants underwent VQ-SPECT-CT using 99mTc-Technegas for V and 99mTc-macroaggregated albumin for Q, spirometry, six-minute-walk-test, blood draw and completed the modified Medical Research Council (mMRC) dyspnea-scale and St. Georges Respiratory Questionnaire (SGRQ). VQ-SPECT-CT was reviewed to report lung function and structure abnormalities and ventilation-heterogeneity was quantified to evaluate associations with symptoms, exercise-capacity and inflammatory markers. MEASUREMENTS AND MAIN RESULTS: Of 25 post-COVID-19 participants, 9 were hospitalized and 16 home-isolated during acute-infection. A total of 88% of hospitalized and 44% of home-isolated participants were reported to have V defects (matched VQ defects: 63% and 44%; mismatched V defects: 38% and 13%), compared to 30% of never-COVID-19 controls (matched VQ defects: 30%, mismatched V defects: 10%) (P = 0.02 and P = 0.68, respectively). Ventilation-heterogeneity was greater in hospitalized (P = 0.003), but not home-isolated participants, compared to the never-COVID-19 controls. Post-COVID-19 ventilation-heterogeneity correlated with the dyspnea-scale (r = 0.45, P = 0.03), SGRQ-score (r = 0.41, P = 0.04), 6MWD (r=-0.49, P = 0.02), SpO2 (P = -0.55, P = 0.005), CT parenchymal opacities (r = 0.42, P = 0.04) and neutrophil percent (r = 0.45, P = 0.04), but not pro-inflammatory cytokines, C-reactive protein or D-dimer. CONCLUSIONS This small functional lung imaging study revealed ventilation impairment in individuals with no history of lung disease recovering from noncritical COVID-19 that was associated with parenchymal opacities, respiratory symptoms and exercise-capacity.